Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.294 USD | +0.67% | -9.54% | +75.00% |
May. 14 | Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
Apr. 02 | Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024 |
Business Summary
Number of employees: 32
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Odor-No-More Environmental
93.5
%
| 4 | 74.3 % | 11 | 93.5 % | +161.55% |
BioLargo Engineering, Science & Technologies
19.6
%
| 2 | 33.0 % | 2 | 19.6 % | +23.37% |
Intersegment
-13.5
%
| 0 | -8.4 % | -2 | -13.5 % | +234.75% |
BioLargo Canada
0.2
%
| 0 | 0.0 % | 0 | 0.2 % | +2,900.00% |
Clyra Medical
0.2
%
| 0 | 1.0 % | 0 | 0.2 % | -64.29% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 12 | 100.0 % | +107.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Charles Dargan
DFI | Director of Finance/CFO | 68 | 08-01-31 |
Chief Operating Officer | 55 | 02-05-31 | |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Mitch Noto
PRN | Corporate Officer/Principal | - | - |
Tonya Chandler
SAM | Sales & Marketing | - | - |
A. J. Sexton
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 06-04-27 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Chief Operating Officer | 55 | 02-05-31 | |
Jack Strommen
BRD | Director/Board Member | 54 | 17-05-31 |
Linda Park
BRD | Director/Board Member | 46 | 22-10-31 |
Christina Bray
BRD | Director/Board Member | - | 22-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 296,839,523 | 254,710,274 ( 85.81 %) | 0 | 85.81 % |
Company contact information
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.00% | 87.02M | |
+3.38% | 104B | |
-7.54% | 62.39B | |
+72.86% | 48.95B | |
+18.82% | 39.58B | |
+3.62% | 32.08B | |
+12.35% | 20.22B | |
+13.00% | 16.86B | |
+16.25% | 14.88B | |
+2.22% | 13.99B |
- Stock Market
- Equities
- BLGO Stock
- Company BioLargo, Inc.